Soluble MICB serum levels correlate with disease stage and survival rate in patients with oral squamous cell carcinoma.
Tamaki
Shigehiro
S
Department of Oral and Maxillofacial Surgery, Nara Medical University, Kashihara, Nara, Japan. tamakitama@Zeus.eonet.ne.jp
Kawakami
Masayoshi
M
Ishitani
Akiko
A
Kawashima
Wataru
W
Kasuda
Shogo
S
Yamanaka
Yasutsugu
Y
Shimomura
Hiroyuki
H
Imai
Yuichiro
Y
Nakagawa
Yousuke
Y
Hatake
Katsuhiko
K
Kirita
Tadaaki
T
D000328:Adult; D000368:Aged; D000369:Aged, 80 and over; D014408:Biomarkers, Tumor / Q000097:blood*; D002294:Carcinoma, Squamous Cell / Q000097:blood* / Q000473:pathology; D004797:Enzyme-Linked Immunosorbent Assay; D005260:Female; D015395:Histocompatibility Antigens Class I / Q000096:biosynthesis / Q000097:blood*; D006801:Humans; D008297:Male; D008875:Middle Aged; D009062:Mouth Neoplasms / Q000097:blood* / Q000473:pathology; D009367:Neoplasm Staging
D014408:Biomarkers, Tumor; D015395:Histocompatibility Antigens Class I; C098080:MICB antigen